DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 171 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $36,291,000 | -7.2% | 1,068,000 | 0.0% | 0.57% | -16.2% |
| Q2 2021 | $39,099,000 | -2.4% | 1,068,000 | +19.6% | 0.68% | -1.7% |
| Q1 2021 | $40,042,000 | -46.0% | 893,000 | -31.3% | 0.69% | -45.9% |
| Q4 2020 | $74,191,000 | -20.5% | 1,300,000 | -28.6% | 1.28% | -3.7% |
| Q3 2020 | $93,366,000 | -15.9% | 1,820,000 | -2.2% | 1.33% | -39.6% |
| Q2 2020 | $111,079,000 | +34.9% | 1,860,000 | -7.0% | 2.20% | -21.0% |
| Q1 2020 | $82,340,000 | +127.9% | 2,000,000 | +53.8% | 2.78% | +161.9% |
| Q4 2019 | $36,130,000 | – | 1,300,000 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |